Abstract
Paracoccus carotinifaciens is an aerobic Gram-negative bacterium that exhibits motility by a peritrichous flagellum. It produces a carotenoid mixture containing astaxanthin as the main component. Selective breeding of P. carotinifaciens has been performed using classical techniques for mutation induction, such as chemical treatment and ultraviolet irradiation, and not using genetic engineering technology. The commercial production of astaxanthin with P. carotinifaciens has been established by optimizing fermentation medium and conditions in the process. Dehydrated P. carotinifaciens is used as a coloring agent for farmed fish and egg yolks. Compared with the administration of chemically synthesized astaxanthin, dehydrated P. carotinifaciens imparts more natural coloration, which is favored by consumers. In addition, astaxanthin-rich carotenoid extracts (ARE) derived from P. carotinifaciens are developed for human nutrition. Animal and clinical studies with ARE for evaluating its efficacy have been conducted and suggested that ARE would be useful for preventing anxiety, stomach ulcer, and retinal damage, as well as improving cognitive function. The efficacy is anticipated to result from not only astaxanthin but also other carotenoids in ARE, such as adonirubin and adonixanthin, in some studies. Hence, astaxanthin commercially produced with P. carotinifaciens has been applied widely in animals and humans.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Food and Drug Administration (2017) GRAS Notice for astaxanthin-rich carotenoid extracts from Paracoccus carotinifaciens. https://www.fda.gov/downloads/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/ucm584383.pdf
Hayashi M, Ishibashi T, Maoka T (2018) Effect of astaxanthin-rich extract derived from Paracoccus carotinifaciens on cognitive function in middle-aged and older individuals. J Clin Biochem Nutr 62:195–205
Inoue Y, Shimazawa M, Nagano R et al (2017) Astaxanthin analogs, adonixanthin and lycopene, activate Nrf2 to prevent light-induced photoreceptor degeneration. J Pharmacol Sci 134:147–157
Ishibashi T (2015) Commercial production of carotenoids using Paracoccus carotinifaciens. Seibutsu-kogaku Kaishi 93:389–390. (in Japanese)
Iwata S, Imai T, Shimazawa M et al (2018) Protective effects of the astaxanthin derivative, adonixanthin, on brain hemorrhagic injury. Brain Res 1698:130–138
Johnson EA (2003) Phaffia rhodozyma: colorful odyssey. Int Microbiol 6:169–174
Katsumata T, Ishibashi T, Kyle D (2014) A sub-chronic toxicity evaluation of a natural astaxanthin-rich carotenoid extract of Paracoccus carotinifaciens in rats. Toxicol Rep 25:582–588
Lerfall J, Bendiksen EA, Olsen JV et al (2016) A comparative study of organic- versus conventional farmed Atlantic salmon. I. Pigment and lipid content and composition, and carotenoid stability in ice-stored filets. Aquaculture 451:170–177
Maoka T, Yasui H, Ohmori A et al (2013) Anti-oxidative, anti-tumor-promoting, and anti-carcinogenic activities of adonirubin and adonixanthin. J Oleo Sci 62:181–186
Maoka T, Kawashima Y, Takaki M (2018) Structures of yellow xanthophylls and metabolism of astaxanthin in the prawn Penaeus japonicus. J Oleo Sci 67:1425–1433
Misawa N, Satomi Y, Kondo K et al (1995) Structure and functional analysis of a marine bacterial carotenoid biosynthesis gene cluster and astaxanthin biosynthetic pathway proposed at the gene level. J Bacteriol 177:6575–6584
Murata K, Oyagi A, Takahira D et al (2012) Protective effects of astaxanthin from Paracoccus carotinifaciens on murine gastric ulcer models. Phytother Res 26:1126–1132
Nishioka Y, Oyagi A, Tsuruma K et al (2011) The antianxiety-like effect of astaxanthin extracted from Paracoccus carotinifaciens. Biofactors 37:25–30
Otsuka T, Shimazawa M, Inoue Y et al (2016) Astaxanthin protects against retinal damage: evidence from in vivo and in vitro retinal ischemia and reperfusion models. Curr Eye Res 41:1465–1472
Sato W, Kuwahara D, Hirasawa K (2017) Analysis of mutant enzyme in high-producing carotenoids strain. Oral presented at 13th Japanese Society of Astaxanthin, Kyoto Prefectural University of Medicine, Kyoto, 9 September 2017
Sehiedt K, Foss P, Storebakken T et al (1989) Metabolism of carotenoids in salmonids—I. idoxanthin, a metabolite of astaxanthin in the flesh of Atlantic salmon (salmon Salar, L.) under varying external conditions. Comp Biochem Physiol B Biochem Mol Biol 92:277–281
Shah MM, Liang Y, Cheng JJ et al (2016) Astaxanthin-producing green microalga Haematococcus pluvialis: from single cell to high value commercial products. Front Plant Sci 7:531
Tsubokura A (2010) Development of “Panaferd-AX”. Seibutsu-kogaku Kaishi 88:492–493. (in Japanese)
Tsubokura A, Yoneda H, Mizuta H (1999) Paracoccus carotinifaciens sp. nov., a new aerobic Gram-negative astaxanthin-producing bacterium. Int J Syst Bacteriol 49:277–282
Watanabe T, Miki W (1993) Astaxanthin: an effective dietary compound for red sea bream broodstock. Colloq INRA 61:27–36
Yamashita E (2015) Let astaxanthin be thy medicine. PharmaNutrition 3:115–122
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Hayashi, M., Ishibashi, T., Kuwahara, D., Hirasawa, K. (2021). Commercial Production of Astaxanthin with Paracoccus carotinifaciens. In: Misawa, N. (eds) Carotenoids: Biosynthetic and Biofunctional Approaches. Advances in Experimental Medicine and Biology, vol 1261. Springer, Singapore. https://doi.org/10.1007/978-981-15-7360-6_2
Download citation
DOI: https://doi.org/10.1007/978-981-15-7360-6_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7359-0
Online ISBN: 978-981-15-7360-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)